Edoxaban, an oral direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro

被引：0
|
作者：
Morishima, Y. [1 ]
Honda, Y. [1 ]
Kamisato, C. [1 ]
机构：
[1] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：688 / 688
页数：1
相关论文
共 50 条
  • [31] Apixaban: an Oral Direct Factor-Xa Inhibitor
    Jimenez, David
    Yusen, Roger D.
    Ramacciotti, Eduardo
    ADVANCES IN THERAPY, 2012, 29 (03) : 187 - 201
  • [32] Apixaban: an Oral Direct Factor-Xa Inhibitor
    David Jiménez
    Roger D. Yusen
    Eduardo Ramacciotti
    Advances in Therapy, 2012, 29 : 187 - 201
  • [33] Effects of dabigatran, a direct thrombin inhibitor, as compared to the direct factor Xa inhibitors, rivaroxaban and apixaban, on tissue factor-induced human platelet aggregation in platelet rich plasma.
    van Ryn, Joanne
    Kink-Eiband, Monika
    Hauel, Norbert
    Priepke, Henning
    Wienen, Wolfgang
    BLOOD, 2007, 110 (11) : 558A - 558A
  • [34] An oral anticoagulant with direct Factor-Xa-inhibitor
    Weiche, Iris
    NERVENHEILKUNDE, 2010, 29 (05) : 320 - 320
  • [35] Apixaban, an oral, direct inhibitor of activated Factor Xa
    Shantsila, Eduard
    Lip, Gregory Y. H.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (09) : 1020 - 1033
  • [36] Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor
    Abrams, Paris J.
    Emerson, Christopher R.
    PHARMACOTHERAPY, 2009, 29 (02): : 167 - 181
  • [37] Rivaroxaban, the first oral, direct factor Xa inhibitor
    Fassiadis, Nicholas
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (18) : 2945 - 2946
  • [38] EdoxabanA New Oral Direct Factor Xa Inhibitor
    A. John Camm
    Henri Bounameaux
    Drugs, 2011, 71 : 1503 - 1526
  • [39] A Direct Oral Factor Xa Inhibitor Edoxaban Ameriorates Hepatic Ischemia-Reperfusion Injury
    Maeda, K.
    Kuriyama, N.
    Sakamoto, T.
    Kaluba, B.
    Yuge, T.
    Noguchi, D.
    Ito, T.
    Gyoten, K.
    Hayasaki, A.
    Fujii, T.
    Iizawa, Y.
    Murata, Y.
    Tanemura, A.
    Kishiwada, M.
    Mizuno, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S914 - S915
  • [40] In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban
    Gerotziafas, G. T.
    Elalamy, I.
    Depasse, F.
    Perzborn, E.
    Samama, M. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 886 - 888
12345